加载中
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
前收盘价
US$28.95
+US$1.47 · +5.35%
盘后
US$29.5791
+US$0.6291 · +2.17%
10月12日 19:40 ET
盘中时间采用ET。市场数据可能有所延迟。
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
日内区间
当前US$28.95
52周区间
当前US$28.95
盘中时间采用ET。市场数据可能有所延迟。
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
日内区间
当前US$28.95
52周区间
当前US$28.95
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 |
|---|---|---|
| 研究与开发 | 1.26亿 USD | 1.01亿 USD |
| 销售、一般及管理费用 | 2649.6万 USD | 2529.6万 USD |
| 营业费用 | 1.52亿 USD | 1.26亿 USD |
| 利息收入 | 338.6万 USD | 640.8万 USD |
| 利息支出 | 152.2万 USD | 148.6万 USD |
| 折旧和摊销 | 250万 USD | 210万 USD |
| 营业利润 | −1.52亿 USD | −1.26亿 USD |
| 净利润 | −1.46亿 USD | −1.18亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$40.00
上涨空间 38.17%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI4373.02万0.00%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard Morningstar Small-Cap ETFVB3158万0.02%1853亿 USD0.03%US$288.16-0.46%
iShares Russell 2000 ETFIWM2846.97万0.04%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap Value ETFVBR1003.26万0.01%682亿 USD0.05%US$234.71+0.12%
Vanguard Morningstar Small-Cap Growth ETFVBK899.27万0.02%447亿 USD0.05%US$340.88-1.12%
iShares Russell 2000 Growth ETFIWO607.27万0.04%139.17亿 USD0.24%US$353.71-0.86%
Schwab U.S. Small-Cap ETFSCHA513.96万0.02%218.24亿 USD0.03%US$32.66-0.40%
Fidelity Blue Chip Growth ETFFBCG273.85万0.04%76.2亿 USD0.57%US$63.40-0.89%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap Value ETFVBRVanguard Morningstar Small-Cap Growth ETFVBKiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAFidelity Blue Chip Growth ETFFBCGAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
